China Medical Biotech Association

QuickTime™ and a TIFF (Uncompressed) decompressor are needed to see this picture.

Welcome to Bio-VC Forum 2008Theme：Invest in Biotechnology, Invest for the FutureTime：October 11-13, 2008Venue: Dalian Modern MuseumDalian · China, 2008 VC Forum Agenda Presented by China Medical Biotech Association

&BIT Life Sciences, Inc., China

OCTOBER 10, 2008, FRIEDAY08:30-18:00 Registration

OPENING CEREMONY & WELCOME SPEECHESDAY ONE: OCTOBER 11, 2008, SATURDAY

07:00-08:30 REGISTRATION AND CONTINENTAL BREAKFAST

08:15-08:30 Group Picture

09:00-09:30 OPENING CEREMONY & WELCOME SPEECHES

VIP ADDRESSESModerator: Xiaodan Mei, Ph.D.President of BIT Life Sciences, Inc., China WELCOMEXiaodan Mei, Ph.D., President & CEO, BITeomics, Inc., ChinaOPENING REMARKS – CONFERENCE CHAIRMr. Hailin Liu , Deputy Director General, China Medicinal Biotech Association WELCOME SPEECHES FROM ORGANIZERS AND HOSTS

1. Leader of Local Municipal Government 2. David A. Palella, President, BioScience Ventures, Inc., USA 09:30-12:00 OPENING FORUM: KEYNOTE SPEECHES Session Chair: Xiaodan Mei, Ph.D. CEO, BIT Life Sciences, Inc., China 09:30-10:00 Keynote Speech: Big Pharma and its Relationship with VC and Biotech Mr. Alex Fowkes, Head of Strategic Alliances, Asia, Global Research & Development, Pfizer (China) Research and Development Co., Ltd.

10:00-10:30 Keynote Speech: Asia's position and outlook in the life sciences industry Partner and Head of China Life Sciences, L.E.K. Consulting

10:30-11:00 Keynote Speech: Creating a Winning Life Sciences Innovation Strategy in an Era of Scarcity Mr. Steve Brown, Founder, Health Hero Network (acquired by Robert Bosch GmbH); Former EIR at Mohr Davidow Ventures; Chairman, Billionlights Foundation

11:00-12:00 PANEL DISCUSSION-Challenges and Opportunities of BiotechnologyModerator: Helen Chen, Partner and Head of China Life Sciences, L.E.K. Consulting (Reserved)

1. Greg Scott,President, ChinaBio™ Accelerator, USA 2. Alex Fowkes, Head of Strategic Alliances, Asia, Global Research & Development, Pfizer (China) Research and Development Co., Ltd. 3. Steve Brown, Founder, Health Hero Network (acquired by Robert Bosch GmbH); Former EIR at Mohr Davidow Ventures; Chairman, Billionlights Foundation 4. David A. Palella, President, BioScience Ventures, Inc., USA 12:00-13:00 LUNCH BREAK

KEYNOTE SESSION I: CHINA BIOTECH – NEW VENTURE FRONTIERDAY 2: OCTOBER 12, 2008 (Sunday Morning)

Moderator: Mr. Alan S. PaauVice Provost, Technology Transfer & Economic Development, Cornell University, USA; Executive Director, Cornell Center for Technology Enterprise & Commercialization (CCTEC), USA

09:00-09:25 Keynote Title: Life Sciences Ventures in China: 15 years of Dramatic Change Hsu, Partner, Bay City Capital, USA

09:25-09:50 Keynote Title: Open Innovation as a Business Model - Roles of Academic Technology TransferMr. Alan S. Paau, Vice Provost, Technology Transfer & Economic Development, Cornell University; Executive Director, Cornell Center for Technology Enterprise & Commercialization (CCTEC), USA

09:50-10:15 Keynote Speech: Merck’s Strategies of Pharma Innovations in ChinaMs. Jing-Shan (Jennifer) Hu, Director, Licensing & External Research (Mainland China, Hong Kong, & Taiwan), Worldwide Licensing & External Researcher, Merck & Co., USA

10:15-10:30 COFFEE BREAK

Parallel Bio-VC Session Ⅱ: Opportunities & Challenges of Bio-Venture In China OCTOBER 12, 2008 (Sunday Morning) Moderator: Mr. Tien-Lai HwangManaging Director and General Manager, Acorn Campus Shanghai Management Co., Ltd

SPEECHES:

10:30-10:55 Title: Innovation Sourcing in Asia – The Roche Pharma Partnering Approach Grams, Business Development Director, Pharma Partnering AsiaShanghai Roche Pharmaceuticals Ltd, China

10:55-11:20 Title: Bio-Venture in China Mr. Tien-Lai Hwang, Managing Director and General Manager, Acorn Campus Shanghai Management Co., Ltd

11:20-12:00 PANEL DISCUSSION

Panelists:

1. Mr. Frank Grams, Business Development Director, Pharma Partnering Asia, Shanghai Roche Pharmaceuticals Ltd 2. Mr. Alan S. Paau, Vice Provost, Technology Transfer & Economic Development, Cornell University, USA; Executive Director, Cornell Center for Technology Enterprise & Commercialization (CCTEC), USA 3. Mr. Roy Hua, Managing Partner, Columbus Growth, USA 4. Ms. Jing-Shan (Jennifer) Hu, Director, Licensing & External Research (Mainland China, Hong Kong, & Taiwan), Worldwide Licensing & External Researcher, Merck & Co., USA 5. Mr. Wai-Yan Sandy Chau, Managing Director, Acorn Campus Ventures, USA 6. Mr. Charles Hsu, Partner, Bay City Capital, USA 12:00-13:00 LUNCH BREAK

Parallel Bio-VC Session Ⅲ: New Bio or Pharma Business Models and Novel Fund-raising Vehicles in China OCTOBER 12, 2008 (Sunday Morning)

Moderator: Paul A. DeRidderVenture Partner, Crystal Cove Capital LLC, USA

SPEECHES:

10:30-10:55 Title: China VC Market Landscape and OutlookMr. York Chen, President, iD Tech Ventures

10:55-11:20 Title: WI Harper Group Case StudiesMr. Wayne Shiong, Partner, WI Harper Group, China

Panelists:

1. Ian Goh, Partner, KPCB, China 2. Xin Sylvia He, Director, Cofounder, Former CEO, RHEI Pharmaceuticals, China 3. York Chen, Partner, iD TechVentures, China 4. Hui Hsing Ma, Partner, TVM Capital 12:00-13:00 LUNCH BREAK

Bio-VC SessionⅣ: How to Set up Good CMO, CRO of R & D BusinessDAY 3: OCTOBER 13, 2008 (Monday Morning)

Moderator: David A. PalellaPresident, BioScience Ventures, Inc., USA

SPEECHES:

09:00-09:30 Title: From Chemical to Clinical Trial William Hu (Hu XuBo), Partner, Qiming Venture Partners, China

09:30-10:00 Title: Global Life Science Mind-to-Market Solution in China George Peng, Venturepharm Group, China

10:00-11:00 PANEL DISCUSSION:

Panelists:

1. William Hu, (Hu XuBo), Partner, Qiming Venture Partners, China 2. George Peng, Vice President, Venturepharm Group, China 3. William Pay, Vice President, Strategic Development & Partner EngagementGlobal Clinical Services, Venturepharm Asia/ VPS CRO Group, USA 12:00-13:00 LUNCH BREAK

Bio-VC Session Ⅴ:How to Obtain Seeding Money or Find Angel InvestorsOCTOBER 13, 2008 (Monday Morning)

Moderator: Greg ScottPresident, ChinaBio™ Accelerator, USA

SPEECHES:

09:00-09:30 Title: VC and Angel Investment in China Biotech Greg Scott, President, ChinaBio™ Accelerator, USA

09:30-10:00 Title: How to Invest Early Phase Biotech Companies Grace Zhang, Atlas China

Panelists:

1. Marc Schuele, Managing partner, DSM Venturing, The Netherlands 2. Yi Shi, Ph.D., Managing Director, Lilly Asian Ventures, China 3. Michael L. Huang, AVP, CX Venture Capital Group, Taiwan 12:00-13:00 LUNCH BREAK